Understanding drug addiction: a neuropsychological perspective

References

• Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 2001; 39: 376–389
   PubMed Web of Science ®Google Scholar
• Fillmore MT. Drug abuse as a problem of impaired control: current approaches and findings. Behav Cogn Neurosci Rev 2003; 2: 179–197
   PubMedGoogle Scholar
• Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002; 159: 1642–1652
   PubMed Web of Science ®Google Scholar
• Grant S, Contoreggi C, London ED. Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia 2000; 38: 1180–1187
   PubMed Web of Science ®Google Scholar
• Jentsch JD, Taylor JR. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 1999; 146: 373–390
   PubMed Web of Science ®Google Scholar
• Lubman DI, Yucel M, Pantelis C. Addiction, a condition of compulsive behaviour? Neuroimaging and neuropsychological evidence of inhibitory dysregulation. Addiction 2004; 99: 1491–1502
   PubMed Web of Science ®Google Scholar
• Yucel M, Lubman DI. Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention. Drug Alcohol Rev 2007; 26: 33–39
   PubMed Web of Science ®Google Scholar
• Volkow ND, Hitzemann R, Wang GJ, et al. Long-term frontal brain metabolic changes in cocaine abusers. Synapse 1992; 11: 184–190
   PubMed Web of Science ®Google Scholar
• Yucel M, Lubman DI, Harrison BJ, et al. A combined spectroscopic and functional MRI investigation of the dorsal anterior cingulate region in opiate addiction. Mol Psychiatry 2007; 12: 691–702
   Web of Science ®Google Scholar
• Yucel M, Lubman DI, Harrison BJ, et al. Neuronal, physiological and brain-behavioural abnormalities in opiate-addicted individuals. Mol Psychiatry 2007; 12: 611
   PubMed Web of Science ®Google Scholar
• Fishbein DH, Herman-Stahl M, Eldreth D, et al. Mediators of the stress-substance-use relationship in urban male adolescents. Prev Sci 2006; 7: 113–126
   PubMed Web of Science ®Google Scholar
• Bowden-Jones H, McPhillips M, Rogers R, Hutton S, Joyce E. Risk-taking on tests sensitive to ventromedial prefrontal cortex dysfunction predicts early relapse in alcohol dependency: a pilot study. J Neuropsychiatry Clin Neurosci 2005; 17: 417–420
   PubMed Web of Science ®Google Scholar
• Scheurich A. Neuropsychological functioning and alcohol dependence. Curr Opin Psychiatry 2005; 18: 319–323
   PubMed Web of Science ®Google Scholar
• Corral-Varela M, Cadaveira F. Neuropsychological aspects of alcohol dependence: the nature of brain damage and its reversibility]. Rev Neurol 2002; 35: 682–687
   PubMed Web of Science ®Google Scholar
• Parsons OA. Neurocognitive deficits in alcoholics and social drinkers: a continuum?. Alcohol Clin Exp Res 1998; 22: 954–961
   PubMed Web of Science ®Google Scholar
• Beatty WW, Tivis R, Stott HD, Nixon SJ, Parsons OA. Neuropsychological deficits in sober alcoholics: influences of chronicity and recent alcohol consumption. Alcohol Clin Exp Res 2000; 24: 149–154
   PubMed Web of Science ®Google Scholar
• Parsons OA, Nixon SJ. Cognitive functioning in sober social drinkers: a review of the research since 1986. J Stud Alcohol 1998; 59: 180–190
   PubMed Web of Science ®Google Scholar
• Eckardt MJ, File SE, Gessa G, et al. Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin Exp Res 1998; 22: 998–1040
   PubMed Web of Science ®Google Scholar
• Solomon DA, Malloy PF. Alcohol, head injury, and neuropsychological function. Neuropsychol Rev 1992; 3: 249–280
   PubMed Web of Science ®Google Scholar
• Mann K, Agartz I, Harper C, et al. Neuroimaging in alcoholism: ethanol and brain damage. Alcohol Clin Exp Res 2001; 25: 104S–109S
   PubMed Web of Science ®Google Scholar
• Pfefferbaum A, Sullivan EV, Mathalon DH, Lim KO. Frontal lobe volume loss observed with magnetic resonance imaging in older chronic alcoholics. Alcohol Clin Exp Res 1997; 21: 521–529
   PubMed Web of Science ®Google Scholar
• Hommer D, Momenan R, Kaiser E, Rawlings R. Evidence for a gender-related effect of alcoholism on brain volumes. Am J Psychiatry 2001; 158: 198–204
   PubMed Web of Science ®Google Scholar
• Hommer D, Momenan R, Rawlings R, et al. Decreased corpus callosum size among alcoholic women. Arch Neurol 1996; 53: 359–363
   PubMed Web of Science ®Google Scholar
• Sullivan EV, Rosenbloom MJ, Lim KO, Pfefferbaum A. Longitudinal changes in cognition, gait, and balance in abstinent and relapsed alcoholic men: relationships to changes in brain structure. Neuropsychology 2000; 14: 178–188
   PubMed Web of Science ®Google Scholar
• Sullivan EV, Rosenbloom MJ, Pfefferbaum A. Pattern of motor and cognitive deficits in detoxified alcoholic men. Alcohol Clin Exp Res 2000; 24: 611–621
   PubMed Web of Science ®Google Scholar
• Volkow ND, Wang GJ, Hitzemann R, et al. Recovery of brain glucose metabolism in detoxified alcoholics. Am J Psychiatry 1994; 151: 178–183
   PubMed Web of Science ®Google Scholar
• Grant I, Gonzalez R, Carey CL, Natarajan L, Wolfson T. Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychol Soc 2003; 9: 679–689
   PubMed Web of Science ®Google Scholar
• Fletcher JM, Page JB, Francis DJ, et al. Cognitive correlates of long-term cannabis use in Costa Rican men. Arch Gen Psychiatry 1996; 53: 1051–1057
   PubMed Web of Science ®Google Scholar
• Pope HG, Jr, Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. JAMA 1996; 275: 521–527
   PubMed Web of Science ®Google Scholar
• Pope HG, Jr, Gruber AJ, Hudson JI, Cohane G, Huestis MA, Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association?. Drug Alcohol Depend 2003; 69: 303–310
   PubMed Web of Science ®Google Scholar
• Pope HG, Jr, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 2001; 58: 909–915
   PubMed Web of Science ®Google Scholar
• Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL. Dose-related neurocognitive effects of marijuana use. Neurology 2002; 59: 1337–1343
   PubMed Web of Science ®Google Scholar
• Solowij N, Stephens RS, Roffman RA, et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 2002; 287: 1123–1131
   PubMed Web of Science ®Google Scholar
• Eldreth DA, Matochik JA, Cadet JL, Bolla KI. Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage 2004; 23: 914–920
   PubMed Web of Science ®Google Scholar
• Solowij N. Cannabis and cognitive functioning. Cambridge University Press, Cambridge 1998
   Google Scholar
• Block RI, O'Leary DS, Ehrhardt JC, et al. Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport 2000; 11: 491–496
   PubMed Web of Science ®Google Scholar
• Kanayama G, Rogowska J, Pope HG, Gruber SA, Yurgelun-Todd DA. Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology (Berl) 2004; 176: 239–247
   PubMed Web of Science ®Google Scholar
• Smith A, Fried P, Hogan M, Cameron I. The effects of prenatal and current marijuana exposure on response inhibition: a functional magnetic resonance imaging study. Brain Cogn 2004; 54: 147–149
   PubMed Web of Science ®Google Scholar
• Gruber SA, Yurgelun-Todd DA. Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation. Brain Res Cogn Brain Res 2005; 23: 107–118
   PubMedGoogle Scholar
• Bolla KI, Eldreth DA, Matochik JA, Cadet JL. Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage 2005; 26: 480–492
   PubMed Web of Science ®Google Scholar
• Matochik JA, Eldreth DA, Cadet JL, Bolla KI. Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend 2005; 77: 23–30
   PubMed Web of Science ®Google Scholar
• Tzilos GK, Cintron CB, Wood JB, et al. Lack of hippocampal volume change in long-term heavy cannabis users. Am J Addict 2005; 14: 64–72
   PubMed Web of Science ®Google Scholar
• Brust J. Neurological aspects of substance abuse. Butterworth-Heinemann, Boston 1993
   Google Scholar
• Lubman DI, Hides L, Yucel M. Inhalant misuse in youth: time for a coordinated response. Med J Aust 2006; 185: 327–330
   PubMed Web of Science ®Google Scholar
• Rosenberg NL, Grigsby J, Dreisbach J, Busenbark D, Grigsby P. Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse. J Toxicol Clin Toxicol 2002; 40: 21–34
   PubMed Web of Science ®Google Scholar
• Maruff P, Burns CB, Tyler P, Currie BJ, Currie J. Neurological and cognitive abnormalities associated with chronic petrol sniffing. Brain 1998; 121(Pt 10)1903–1917
   PubMed Web of Science ®Google Scholar
• Chadwick O, Anderson R, Bland M, Ramsey J. Neuropsychological consequences of volatile substance abuse: a population based study of secondary school pupils. BMJ 1989; 298: 1679–1683
   PubMed Web of Science ®Google Scholar
• Takagi M, Lubman DI, Yücel M. Interpreting neuropsychological impairment amongst adolescent inhalant users: two case reports Acta Neuropsychiatr (in press).
   Google Scholar
• Yamanouchi N, Okada S, Kodama K, et al. White matter changes caused by chronic solvent abuse. AJNR Am J Neuroradiol 1995; 16: 1643–1649
   PubMed Web of Science ®Google Scholar
• Yamanouchi N, Okada S, Kodama K, et al. Effects of MRI abnormalities on WAIS-R performance in solvent abusers. Acta Neurol Scand 1997; 96: 34–39
   PubMed Web of Science ®Google Scholar
• Cairney S, Maruff P, Burns CB, Currie J, Currie BJ. Saccade dysfunction associated with chronic petrol sniffing and lead encephalopathy. J Neurol Neurosurg Psychiatry 2004; 75: 472–476
   PubMed Web of Science ®Google Scholar
• Cairney S, Maruff P, Burns CB, Currie J, Currie BJ. Neurological and cognitive recovery following abstinence from petrol sniffing. Neuropsychopharmacology 2005; 30: 1019–1027
   PubMed Web of Science ®Google Scholar
• Caldemeyer K, Pascuzzi R, Moran C, Smith R. Toluene abuse causing reduced MR signal intensity in the brain. AJR Am J Roentgenol 1993; 161: 1259–1261
   PubMed Web of Science ®Google Scholar
• Ehyai A, Freemon F. Progressive optic neuropathy and sensorineural hearing loss due to chronic glue sniffing. J Neurol Neurosurg Psychiatry 1983; 46: 349–348
   PubMed Web of Science ®Google Scholar
• Ryu Y, Lee J, Yoon P, Jeon P, Kim D, Shin D. Cerebral perfusion impairment in a patient with toluene abuse. J Nucl Med 1998; 39: 632–633
   PubMed Web of Science ®Google Scholar
• Aydin K, Sencer S, Ogel K, Genchellac H, Demir T, Minareci O. Single-voxel proton MR spectroscopy in toluene abuse. Magn Reson Imaging 2003; 21: 777–785
   PubMed Web of Science ®Google Scholar
• Filley C, Heaton RK, Rosenberg NL. White matter dementia in chronic toluene abuse. Neurology 1990; 40: 532–534
   PubMed Web of Science ®Google Scholar
• Deleu D, Hanssens Y. Toluene induced postural tremor. J Neurol Neurosurg Psychiatry 2000; 68: 118
   PubMed Web of Science ®Google Scholar
• Rosenberg NI, Kleinschmidt-DeMasters BK, Davis KA, Dreisbach JN, Hormes JT, Filley CM. Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol 1988; 23: 611–614
   PubMed Web of Science ®Google Scholar
• Davis PE, Liddiard H, McMillan TM. Neuropsychological deficits and opiate abuse. Drug Alcohol Depend 2002; 67: 105–108
   PubMed Web of Science ®Google Scholar
• Pau CW, Lee TM, Chan SF. The impact of heroin on frontal executive functions. Arch Clin Neuropsychol 2002; 17: 663–670
   PubMed Web of Science ®Google Scholar
• Guerra D, Sole A, Cami J, Tobena A. Neuropsychological performance in opiate addicts after rapid detoxification. Drug Alcohol Depend 1987; 20: 261–270
   PubMed Web of Science ®Google Scholar
• Ornstein TJ, Iddon JL, Baldacchino AM, et al. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 2000; 23: 113–126
   PubMed Web of Science ®Google Scholar
• Rogers RD, Everitt BJ, Baldacchino A, et al. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 1999; 20: 322–339
   PubMed Web of Science ®Google Scholar
• Lee TM, Pau CW. Impulse control differences between abstinent heroin users and matched controls. Brain Inj 2002; 16: 885–889
   PubMed Web of Science ®Google Scholar
• Darke S, Sims J, McDonald S, Wickes W. Cognitive impairment among methadone maintenance patients. Addiction 2000; 95: 687–695
   PubMed Web of Science ®Google Scholar
• Ersche KD, Fletcher PC, Lewis SJ, et al. Abnormal frontal activations related to decision-making in current and former amphetamine and opiate dependent individuals. Psychopharmacology (Berl) 2005; 180: 612–623
   PubMed Web of Science ®Google Scholar
• Lyoo IK, Pollack MH, Silveri MM, et al. Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology (Berl) 2006; 184: 139–144
   PubMed Web of Science ®Google Scholar
• Kivisaari R, Kahkonen S, Puuskari V, Jokela O, Rapeli P, Autti T. Magnetic resonance imaging of severe, long-term, opiate-abuse patients without neurologic symptoms may show enlarged cerebrospinal spaces but no signs of brain pathology of vascular origin. Arch Med Res 2004; 35: 395–400
   PubMed Web of Science ®Google Scholar
• Ersche KD, Clark L, London M, Robbins TW, Sahakian BJ. Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology 2006; 31: 1036–1047
   PubMed Web of Science ®Google Scholar
• Maxwell JC. Emerging research on methamphetamine. Curr Opin Psychiatry 2005; 18: 235–242
   PubMed Web of Science ®Google Scholar
• Nordahl TE, Salo R, Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. J Neuropsychiatry Clin Neurosci 2003; 15: 317–325
   PubMed Web of Science ®Google Scholar
• Rippeth JD, Heaton RK, Carey CL, et al. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 2004; 10: 1–14
   PubMed Web of Science ®Google Scholar
• Salo R, Nordahl TE, Possin K, et al. Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Res 2002; 111: 65–74
   PubMed Web of Science ®Google Scholar
• Gonzalez R, Rippeth JD, Carey CL, et al. Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug Alcohol Depend 2004; 76: 181–190
   PubMed Web of Science ®Google Scholar
• Woods SP, Rippeth JD, Conover E, et al. Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. Neuropsychology 2005; 19: 35–43
   PubMed Web of Science ®Google Scholar
• Strickland TL, Mena I, Villanueva-Meyer J, et al. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci 1993; 5: 419–427
   PubMed Web of Science ®Google Scholar
• Bolla KI, Rothman R, Cadet JL. Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci 1999; 11: 361–369
   PubMed Web of Science ®Google Scholar
• Rogers RD, Robbins TW. Investigating the neurocognitive deficits associated with chronic drug misuse. Curr Opin Neurobiol 2001; 11: 250–257
   PubMed Web of Science ®Google Scholar
• Ardila A, Rosselli M, Strumwasser S. Neuropsychological deficits in chronic cocaine abusers. Int J Neurosci 1991; 57: 73–79
   PubMed Web of Science ®Google Scholar
• Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, et al. Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG. Neuropsychopharmacology 1999; 20: 565–581
   PubMed Web of Science ®Google Scholar
• Iyo M, Namba H, Yanagisawa M, Hirai S, Yui N, Fukui S. Abnormal cerebral perfusion in chronic methamphetamine abusers: a study using 99MTc-HMPAO and SPECT. Prog Neuropsychopharmacol Biol Psychiatry 1997; 21: 789–796
   PubMed Web of Science ®Google Scholar
• Volkow ND, Chang L, Wang GJ, et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001; 158: 2015–2021
   PubMed Web of Science ®Google Scholar
• Volkow ND, Chang L, Wang GJ, et al. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 2001; 21: 9414–9418
   PubMed Web of Science ®Google Scholar
• Volkow ND, Chang L, Wang GJ, et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 2001; 158: 377–382
   PubMed Web of Science ®Google Scholar
• Thompson PM, Hayashi KM, Simon SL, et al. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 2004; 24: 6028–6036
   PubMed Web of Science ®Google Scholar
• Ernst T, Chang L, Leonido-Yee M, Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 2000; 54: 1344–1349
   PubMed Web of Science ®Google Scholar
• Nordahl TE, Salo R, Natsuaki Y, et al. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 2005; 62: 444–452
   PubMed Web of Science ®Google Scholar
• Nordahl TE, Salo R, Possin K, et al. Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy. Psychiatry Res 2002; 116: 43–52
   PubMed Web of Science ®Google Scholar
• Bartzokis G, Beckson M, Lu PH, et al. Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research. Psychiatry Res 2000; 98: 93–102
   PubMed Web of Science ®Google Scholar
• Di Sclafani V, Tolou-Shams M, Price LJ, Fein G. Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug Alcohol Depend 2002; 66: 161–171
   PubMed Web of Science ®Google Scholar
• Fein G, Di Sclafani V, Meyerhoff DJ. Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men. Drug Alcohol Depend 2002; 68: 87–93
   PubMed Web of Science ®Google Scholar
• Gouzoulis-Mayfrank E, Daumann J. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?. Addiction 2006; 101: 348–361
   PubMed Web of Science ®Google Scholar
• McGuire P. Long term psychiatric and cognitive effects of MDMA use. Toxicol Lett 2000; 112–113: 153–156
   PubMed Web of Science ®Google Scholar
• Montoya AG, Sorrentino R, Lukas SE, Price BH. Long-term neuropsychiatric consequences of “ecstasy” (MDMA): a review. Harv Rev Psychiatry 2002; 10: 212–220
   PubMed Web of Science ®Google Scholar
• Bolla KI, McCann UD, Ricaurte GA. Memory impairment in abstinent MDMA (“Ecstasy”) users. Neurology 1998; 51: 1532–1537
   PubMed Web of Science ®Google Scholar
• McCardle K, Luebbers S, Carter JD, Croft RJ, Stough C. Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology (Berl) 2004; 173: 434–439
   PubMed Web of Science ®Google Scholar
• Morgan MJ, Impallomeni LC, Pirona A, Rogers RD. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naive controls. Neuropsychopharmacology 2006; 31: 1562–1573
   PubMed Web of Science ®Google Scholar
• Spatt J, Glawar B, Mamoli B. A pure amnestic syndrome after MDMA (“ecstasy”) ingestion. J Neurol Neurosurg Psychiatry 1997; 62: 418–419
   PubMed Web of Science ®Google Scholar
• Jacobsen LK, Mencl WE, Pugh KR, Skudlarski P, Krystal JH. Preliminary evidence of hippocampal dysfunction in adolescent MDMA (“ecstasy”) users: possible relationship to neurotoxic effects. Psychopharmacology (Berl) 2004; 173: 383–390
   PubMed Web of Science ®Google Scholar
• Daumann J, Fischermann T, Heekeren K, Henke K, Thron A, Gouzoulis-Mayfrank E. Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users. Psychopharmacology (Berl) 2005; 180: 607–611
   PubMed Web of Science ®Google Scholar
• Daumann J, Jr, Fischermann T, Heekeren K, Thron A, Gouzoulis-Mayfrank E. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study. Biol Psychiatry 2004; 56: 349–355
   PubMed Web of Science ®Google Scholar
• Daumann J, Pelz S, Becker S, Tuchtenhagen F, Gouzoulis-Mayfrank E. Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use. Hum Psychopharmacol 2001; 16: 627–633
   PubMed Web of Science ®Google Scholar
• Daumann J, Schnitker R, Weidemann J, Schnell K, Thron A, Gouzoulis-Mayfrank E. Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users. Neuroreport 2003; 14: 1983–1987
   PubMed Web of Science ®Google Scholar
• Cowan RL, Lyoo IK, Sung SM, et al. Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study. Drug Alcohol Depend 2003; 72: 225–235
   PubMed Web of Science ®Google Scholar
• Morgan MJ, McFie L, Fleetwood H, Robinson JA. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?. Psychopharmacology (Berl) 2002; 159: 294–303
   PubMed Web of Science ®Google Scholar
• Jacobsen LK, Pugh KR, Constable RT, Westerveld M, Mencl WE. Functional correlates of verbal memory deficits emerging during nicotine withdrawal in abstinent adolescent cannabis users. Biol Psychiatry 2007; 61: 31–40
   PubMed Web of Science ®Google Scholar
• Lewinsohn PM, Hops H, Roberts RE, Seeley JR, Andrews JA. Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol 1993; 102: 133–144
   PubMed Web of Science ®Google Scholar
• Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry 2005; 62: 1097–1106
   PubMed Web of Science ®Google Scholar
• Button TM, Hewitt JK, Rhee SH, Young SE, Corley RP, Stallings MC. Examination of the causes of covariation between conduct disorder symptoms and vulnerability to drug dependence. Twin Res Hum Genet 2006; 9: 38–45
   PubMed Web of Science ®Google Scholar
• Conway KP, Compton W, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006; 67: 247–257
   PubMed Web of Science ®Google Scholar
• Kantojarvi L, Veijola J, Laksy K, et al. Co-occurrence of personality disorders with mood, anxiety, and substance use disorders in a young adult population. J Pers Disord 2006; 20: 102–112
   PubMed Web of Science ®Google Scholar
• Hides L, Lubman DI, Dawe S. Models of co-occurring substance misuse and psychosis: are personality traits the missing link?. Drug Alcohol Rev 2004; 23: 425–432
   PubMed Web of Science ®Google Scholar
• Swartz MS, Wagner HR, Swanson JW, et al. Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. J Nerv Ment Dis 2006; 194: 164–172
   PubMed Web of Science ®Google Scholar
• Bogenschutz MP, Nurnberg HG. Theoretical and methodological issues in psychiatric comorbidity. Harv Rev Psychiatry 2000; 8: 18–24
   PubMed Web of Science ®Google Scholar
• Brady KT, Sinha R. Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. Am J Psychiatry 2005; 162: 1483–1493
   PubMed Web of Science ®Google Scholar
• Tarter RE, Kirisci L, Mezzich A, et al. Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. Am J Psychiatry 2003; 160: 1078–1085
   PubMed Web of Science ®Google Scholar
• Acton GS. Measurement of impulsivity in a hierarchical model of personality traits: implications for substance use. Subst Use Misuse 2003; 38: 67–83
   PubMed Web of Science ®Google Scholar
• Stepp SD, Trull TJ, Sher KJ. Borderline personality features predict alcohol use problems. J Pers Disord 2005; 19: 711–722
   PubMed Web of Science ®Google Scholar
• Dawe S, Gullo MJ, Loxton NJ. Reward drive and rash impulsiveness as dimensions of impulsivity: implications for substance misuse. Addict Behav 2004; 29: 1389–1405
   PubMed Web of Science ®Google Scholar
• Chassin L, Fora DB, King KM. Trajectories of alcohol and drug use and dependence from adolescence to adulthood: the effects of familial alcoholism and personality. J Abnorm Psychol 2004; 113: 483–498
   PubMed Web of Science ®Google Scholar
• Chassin L, Pillow DR, Curran PJ, Molina BS, Barrera M Jr. Relation of parental alcoholism to early adolescent substance use: a test of three mediating mechanisms. J Abnorm Psychol 1993; 102: 3–19
   PubMed Web of Science ®Google Scholar
• Whittle S, Allen NB, Lubman DI, Yucel M. The neurobiological basis of temperament: towards a better understanding of psychopathology. Neurosci Biobehav Rev 2006; 30: 511–525
   PubMed Web of Science ®Google Scholar
• Kirisci L, Tarter RE, Vanyukov M, Reynolds M, Habeych M. Relation between cognitive distortions and neurobehavior disinhibition on the development of substance use during adolescence and substance use disorder by young adulthood: a prospective study. Drug Alcohol Depend 2004; 76: 125–133
   PubMed Web of Science ®Google Scholar
• Giedd JN, Blumenthal J, Jeffries NO, et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 1999; 2: 861–863
   PubMed Web of Science ®Google Scholar
• Gogtay N, Giedd JN, Lusk L, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA 2004; 101: 8174–8179
   PubMed Web of Science ®Google Scholar
• Paus T, Zijdenbos A, Worsley K, et al. Structural maturation of neural pathways in children and adolescents: in vivo study. Science 1999; 283: 1908–1911
   PubMed Web of Science ®Google Scholar
• Paus T. Mapping brain maturation and cognitive development during adolescence. Trends Cogn Sci 2005; 9: 60–68
   PubMed Web of Science ®Google Scholar
• Steinberg L. Cognitive and affective development in adolescence. Trends Cogn Sci 2005; 9: 69–74
   PubMed Web of Science ®Google Scholar
• Scheier LM, Botvin GJ. Effects of early adolescent drug use on cognitive efficacy in early-late adolescence: a developmental structural model. J Subst Abuse 1995; 7: 379–404
   PubMedGoogle Scholar
• Lubman DI, Yücel M, Hall WD. Substances and the adolescent brain: a toxic combination? J Psychopharmacol (in press).
   Web of Science ®Google Scholar
• De Bellis MD, Clark DB, Beers SR, et al. Hippocampal volume in adolescent-onset alcohol use disorders. Am J Psychiatry 2000; 157: 737–744
   PubMed Web of Science ®Google Scholar
• De Bellis MD, Narasimhan A, Thatcher DL, Keshavan MS, Soloff P, Clark DB. Prefrontal cortex, thalamus, and cerebellar volumes in adolescents and young adults with adolescent-onset alcohol use disorders and comorbid mental disorders. Alcohol Clin Exp Res 2005; 29: 1590–1600
   PubMedGoogle Scholar
• Wilson W, Mathew R, Turkington T, Hawk T, Coleman RE, Provenzale J. Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study. J Addict Dis 2000; 19: 1–22
   PubMed Web of Science ®Google Scholar
• Medina KL, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF. Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicol Teratol 2007; 29: 141–152
   PubMed Web of Science ®Google Scholar
• Tapert SF, Cheung EH, Brown GG, et al. Neural response to alcohol stimuli in adolescents with alcohol use disorder. Arch Gen Psychiatry 2003; 60: 727–735
   PubMed Web of Science ®Google Scholar
• Kreek MJ, Nielsen DA, Butelman ER, LaForge KS. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 2005; 8: 1450–1457
   PubMed Web of Science ®Google Scholar
• Diamond A, Briand L, Fossella J, Gehlbach L. Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am J Psychiatry 2004; 161: 125–132
   PubMed Web of Science ®Google Scholar
• Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98: 6917–6922
   PubMed Web of Science ®Google Scholar
• Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 2002; 159: 652–654
   PubMed Web of Science ®Google Scholar
• Beuten J, Payne TJ, Ma JZ, Li MD. Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. Neuropsychopharmacology 2006; 31: 675–684
   PubMed Web of Science ®Google Scholar
• Li T, Chen CK, Hu X, et al. Association analysis of the DRD4 and COMT genes in methamphetamine abuse. Am J Med Genet B Neuropsychiatr Genet 2004; 129: 120–124
   Web of Science ®Google Scholar